切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2022, Vol. 11 ›› Issue (05) : 449 -452. doi: 10.3877/cma.j.issn.2095-3232.2022.05.005

专题笔谈

胰腺导管内乳头状黏液性肿瘤诊治与随访策略
黄晓锐1, 郭通1, 张志威1, 蔡茗1, 郭欣怡1, 王敏1, 俞亚红1,()   
  1. 1. 430000 武汉,华中科技大学同济医学院附属同济医院胆胰外科
  • 收稿日期:2022-05-13 出版日期:2022-10-10
  • 通信作者: 俞亚红
  • 基金资助:
    国家自然科学基金(81773160)

Diagnosis and managements of intraductal papillary mucinous neoplasms and patient follow-up strategy

Xiaorui Huang1, Tong Guo1, Zhiwei Zhang1   

  • Received:2022-05-13 Published:2022-10-10
引用本文:

黄晓锐, 郭通, 张志威, 蔡茗, 郭欣怡, 王敏, 俞亚红. 胰腺导管内乳头状黏液性肿瘤诊治与随访策略[J]. 中华肝脏外科手术学电子杂志, 2022, 11(05): 449-452.

Xiaorui Huang, Tong Guo, Zhiwei Zhang. Diagnosis and managements of intraductal papillary mucinous neoplasms and patient follow-up strategy[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2022, 11(05): 449-452.

胰腺导管内乳头状黏液性肿瘤(intraductal papillary mucinous neoplasms,IPMN)是一种由产生黏蛋白的主胰管或分支胰管赘生性上皮细胞增殖形成的呈乳头状生长并伴有主胰管或分支胰管扩张的胰腺囊性肿瘤。该病于1982年由Ohashi等[1]以"胰腺产黏液癌"的名称首次报道。1996年WHO将产黏液的胰腺肿瘤分为两大类,并于2000年WHO修订版肿瘤组织学分类中正式命名为导管内乳头状黏液性肿瘤和黏液性囊性肿瘤[2]

表1 2017年修订版福冈指南IPMN恶性风险因素[7]
表2 2018年欧洲循证指南IPMN手术指征[9]
[1]
Ohashi K, Murakami Y, Murayama M. Four cases of mucin producing cancer of the pancreas on specific findings of papilla of vater[J]. Prog Dig Endosc, 1982(20):348-351.
[2]
Tanaka MChari SAdsay V,et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas[J]. Pancreatology, 2006, 6(1/2):17-32.
[3]
Chang YRPark JKJang JY,et al. Incidental pancreatic cystic neoplasms in an asymptomatic healthy population of21 745 individuals: large-scale,single-center cohort study[J]. Medicine, 2016, 95(51):e5535.
[4]
Zerboni GSignoretti MCrippa S, et al. Systematic review and meta-analysis: prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individuals[J]. Pancreatology, 2019, 19(1):2-9.
[5]
中华外科青年医师学术研究社胰腺外科研究组. 中国胰腺囊性肿瘤外科诊治现状分析: 2 251例报告[J]. 中华外科杂志201856(1):24-29.
[6]
Nagtegaal ID, Odze RD, Klimstra D, et al. The 2019 WHO classification of tumours of the digestive system[J]. Histopathology, 2020, 76(2):182-188.
[7]
Tanaka M, Fernández-Del Castillo C, Kamisawa T, et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas[J]. Pancreatology, 2017, 17(5):738-753.
[8]
中华医学会外科学分会胰腺外科学组. 胰腺囊性疾病诊治指南(2015版)[J]. 临床肝胆病杂志, 2015, 31(9):1375-1378.
[9]
European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms[J]. Gut, 2018, 67(5):789-804.
[10]
Gemenetzis G, Bagante F, Griffin JF, et al. Neutrophil-to-lymphocyte ratio is a predictive marker for invasive malignancy in intraductal papillary mucinous neoplasms of the pancreas[J]. Ann Surg, 2017, 266(2):339-345.
[11]
Hao S, Takahashi C, Snyder RA, et al. Stratifying intraductal papillary mucinous neoplasms by cyst fluid analysis: present and future[J]. Int J Mol Sci, 2020, 21(3):1147.
[12]
Springer S, Masica DL, Dal Molin M, et al. A multimodality test to guide the management of patients with a pancreatic cyst[J]. Sci Transl Med, 2019, 11(501):eaav4772.
[13]
Lee JH, Kim Y, Choi JW,et al. KRAS, GNAS, and RNF43 mutations in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis[J]. Springerplus, 2016, 5(1):1172.
[14]
Gaujoux S, Parvanescu A, Cesaretti M,et al. GNAs but not extended RAS mutations spectrum are associated with a better prognosis in intraductal pancreatic mucinous neoplasms[J]. Ann Surg Oncol, 2019, 26(8):2640-2650.
[15]
Wang J, Paris PL, Chen J,et al. Next generation sequencing of pancreatic cyst fluid microRNAs from low grade-benign and high grade-invasive lesions[J]. Cancer Lett, 2015, 356(2 Pt B):404-409.
[16]
Kuratomi N, Takano S, Fukasawa M, et al. MiR-10a in pancreatic juice as a biomarker for invasive intraductal papillary mucinous neoplasm by miRNA sequencing[J]. Int J Mol Sci, 2021, 22(6):3221.
[17]
Vege SS, Ziring B, Jain R, et al. American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts[J]. Gastroenterology, 2015, 148(4):819-822.
[18]
Kadiyala V, Lee LS. Endosonography in the diagnosis and management of pancreatic cysts[J]. World J Gastrointest Endosc, 2015, 7(3):213-223.
[19]
Fernández-del Castillo CAdsay NV. Intraductal papillary mucinous neoplasms of the pancreas[J]. Gastroenterology, 2010, 139(3):708-713, e1-2.
[20]
Park JK, Song BJ, Ryu JK, et al. Clinical outcomes of endoscopic ultrasonography-guided pancreatic cyst ablation[J]. Pancreas, 2016, 45(6):889-894.
[1] 杨水华, 何桂丹, 覃桂灿, 梁蒙凤, 罗艳合, 李雪芹, 唐娟松. 胎儿孤立性完全型肺静脉异位引流的超声心动图特征及高分辨率血流联合时间-空间相关成像的应用[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1061-1067.
[2] 陈旭渊, 罗仕云, 李文忠, 李毅. 腺源性肛瘘经手术治疗后创面愈合困难的危险因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 82-85.
[3] 纪凯伦, 郝少龙, 孙海涛, 韩威. 减重术后胆囊结石形成机制的新进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 100-103.
[4] 彭旭, 邵永孚, 李铎, 邹瑞, 邢贞明. 结肠肝曲癌的诊断和外科治疗[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 108-110.
[5] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[6] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[7] 逄世江, 黄艳艳, 朱冠烈. 改良π形吻合在腹腔镜全胃切除消化道重建中的安全性和有效性研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 66-69.
[8] 杨体飞, 杨传虎, 陆振如. 改良无充气经腋窝入路全腔镜下甲状腺手术对喉返神经功能的影响研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 74-77.
[9] 李智铭, 郭晨明, 庄晓晨, 候雪琴, 高军喜. 早期乳腺癌超声造影定性及定量指标的对比研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 639-643.
[10] 陈大敏, 曹晓刚, 曹能琦. 肥胖对胃癌患者手术治疗效果的影响研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 651-653.
[11] 程相阵. 腹茧症9例诊治分析并文献复习[J]. 中华临床医师杂志(电子版), 2023, 17(9): 968-971.
[12] 袁媛, 赵良平, 刘智慧, 张丽萍, 谭丽梅, 閤梦琴. 子宫内膜癌组织中miR-25-3p、PTEN的表达及与病理参数的关系[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1016-1020.
[13] 李田, 徐洪, 刘和亮. 尘肺病的相关研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 900-905.
[14] 周婷, 孙培培, 张二明, 安欣华, 向平超. 北京市石景山区40岁及以上居民慢性阻塞性肺疾病诊断现状调查[J]. 中华临床医师杂志(电子版), 2023, 17(07): 790-797.
[15] 李静, 张玲玲, 邢伟. 兴趣诱导理念用于小儿手术麻醉诱导前的价值及其对家属满意度的影响[J]. 中华临床医师杂志(电子版), 2023, 17(07): 812-817.
阅读次数
全文


摘要